Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
i.e decrease » we decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
Showing 661 - 680 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((i.e decrease) OR (greatest decrease)) ))', query time: 0.46s Refine Results
  1. 661
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 662
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 663
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 664
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 665
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 666
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 667
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 668
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 669
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 670
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 671
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 672
    Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents

    Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents by Marcian E. Van Dort (21374093)

    Published 2025
    “…Additionally, compound LP-65 demonstrated significant modulation of MEK and mTOR signaling activity in human glioma cells (D54) and human melanoma cells (A375), with a corresponding decrease in cellular proliferation and migration. …”
    Save to List
    Saved in:
  13. 673
    Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i>

    Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

    Published 2025
    “…Mouse EAC cells showed a decrease in cell viability starting from 250 µM at 24h of treatment. …”
    Save to List
    Saved in:
  14. 674
    ROC curves for hub genes.

    ROC curves for hub genes. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 675
    Test soil parameters.

    Test soil parameters. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 676
    Differences in immune infiltration between NAFLD and control groups.

    Differences in immune infiltration between NAFLD and control groups. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 677
    Swelling pressure versus free swelling ratio curve.

    Swelling pressure versus free swelling ratio curve. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 678
    Shematic representation for the mechanism of the swelling pressure: (a)soil without added fiber; (b)soil with added fiber.

    Shematic representation for the mechanism of the swelling pressure: (a)soil without added fiber; (b)soil with added fiber. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 679
    Influence of UHMWPE length on swelling pressure.

    Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 680
    UHMWPF parameters.

    UHMWPF parameters. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: